![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 41, 42355-42358, October 8, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



From the Department of Medical Biochemistry and Microbiology, BMC, Box 582, SE-751 23 Uppsala, Sweden
Heparan sulfate structure differs significantly between various cell types and during different developmental stages. The diversity is created during biosynthesis by sulfotransferases, which add sulfate groups to the growing chain, and a C5-epimerase, which converts selected glucuronic acid residues to iduronic acid. All these modifications are believed to depend on initial glucosamine N-sulfation carried out by the enzyme glucosaminyl N-deacetylase/N-sulfotransferase (NDST). Here we report that heparan sulfate synthesized by mouse embryonic stem cells deficient in NDST1 and NDST2 completely lacks N-sulfation but still contains 6-O-sulfate groups, demonstrating that 6-O-sulfation can occur without prior N-sulfation. Reverse transcriptase-PCR analysis indicates that all three identified 6-O-sulfotransferases are expressed by the cells, 6-O-sulfotransferase-1 being the dominating form. The 6-O-sulfated polysaccharide lacking N-sulfate groups also contains N-unsubstituted glucosamine units, raising questions about how these units are generated.
Received for publication, August 5, 2004 , and in revised form, August 19, 2004.
* This work was supported by grants from the Swedish Research Council, the program "Glycoconjugates in Biological Systems" sponsored by the Swedish Foundation for Strategic Research, Polysackarid-forskning AB, and Gustaf V:s 80-årsfond. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
These authors contributed equally to this work.
To whom correspondence should be addressed. Tel.: 46-18-471-4217; Fax: 46-18-471-4244; E-mail: lena.kjellen{at}imbim.uu.se.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Lawrence, S. K. Olson, R. E. Steele, L. Wang, R. Warrior, R. D. Cummings, and J. D. Esko Evolutionary Differences in Glycosaminoglycan Fine Structure Detected by Quantitative Glycan Reductive Isotope Labeling J. Biol. Chem., November 28, 2008; 283(48): 33674 - 33684. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Pallerla, R. Lawrence, L. Lewejohann, Y. Pan, T. Fischer, U. Schlomann, X. Zhang, J. D. Esko, and K. Grobe Altered Heparan Sulfate Structure in Mice with Deleted NDST3 Gene Function J. Biol. Chem., June 13, 2008; 283(24): 16885 - 16894. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pan, C. Carbe, A. Powers, E. E. Zhang, J. D. Esko, K. Grobe, G.-S. Feng, and X. Zhang Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction Development, January 15, 2008; 135(2): 301 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Busse, A. Feta, J. Presto, M. Wilen, M. Gronning, L. Kjellen, and M. Kusche-Gullberg Contribution of EXT1, EXT2, and EXTL3 to Heparan Sulfate Chain Elongation J. Biol. Chem., November 9, 2007; 282(45): 32802 - 32810. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Johnson, B. E. Crawford, M. Stavridis, G. ten Dam, A. L. Wat, G. Rushton, C. M. Ward, V. Wilson, T. H. van Kuppevelt, J. D. Esko, et al. Essential Alterations of Heparan Sulfate During the Differentiation of Embryonic Stem Cells to Sox1-Enhanced Green Fluorescent Protein-Expressing Neural Progenitor Cells Stem Cells, August 1, 2007; 25(8): 1913 - 1923. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jakobsson, J. Kreuger, and L. Claesson-Welsh Building blood vessels--stem cell models in vascular biology J. Cell Biol., June 21, 2007; 177(5): 751 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Habuchi, N. Nagai, N. Sugaya, F. Atsumi, R. L. Stevens, and K. Kimata Mice Deficient in Heparan Sulfate 6-O-Sulfotransferase-1 Exhibit Defective Heparan Sulfate Biosynthesis, Abnormal Placentation, and Late Embryonic Lethality J. Biol. Chem., May 25, 2007; 282(21): 15578 - 15588. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Fuster, L. Wang, J. Castagnola, L. Sikora, K. Reddi, P. H.A. Lee, K. A. Radek, M. Schuksz, J. R. Bishop, R. L. Gallo, et al. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis J. Cell Biol., May 7, 2007; 177(3): 539 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abramsson, S. Kurup, M. Busse, S. Yamada, P. Lindblom, E. Schallmeiner, D. Stenzel, D. Sauvaget, J. Ledin, M. Ringvall, et al. Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development Genes & Dev., February 1, 2007; 21(3): 316 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ledin, M. Ringvall, M. Thuveson, I. Eriksson, M. Wilen, M. Kusche-Gullberg, E. Forsberg, and L. Kjellen Enzymatically Active N-Deacetylase/N-Sulfotransferase-2 Is Present in Liver but Does Not Contribute to Heparan Sulfate N-Sulfation J. Biol. Chem., November 24, 2006; 281(47): 35727 - 35734. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-T. Do, E. Smeds, D. Spillmann, and M. Kusche-Gullberg Overexpression of Heparan Sulfate 6-O-Sulfotransferases in Human Embryonic Kidney 293 Cells Results in Increased N-Acetylglucosaminyl 6-O-Sulfation J. Biol. Chem., March 3, 2006; 281(9): 5348 - 5356. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, F. Y. Avci, E. M. Munoz, L. M. McDowell, M. Chen, L. C. Pedersen, L. Zhang, R. J. Linhardt, and J. Liu Enzymatic Redesigning of Biologically Active Heparan Sulfate J. Biol. Chem., December 30, 2005; 280(52): 42817 - 42825. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Bishop, B. E. Crawford, and J. D. Esko Cell Surface Heparan Sulfate Promotes Replication of Toxoplasma gondii Infect. Immun., September 1, 2005; 73(9): 5395 - 5401. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Grobe, M. Inatani, S. R. Pallerla, J. Castagnola, Y. Yamaguchi, and J. D. Esko Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function Development, August 15, 2005; 132(16): 3777 - 3786. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Baumeister, S. Luo, W. C. Skarnes, G. Sui, E. Seto, Y. Shi, and A. S. Lee Endoplasmic Reticulum Stress Induction of the Grp78/BiP Promoter: Activating Mechanisms Mediated by YY1 and Its Interactive Chromatin Modifiers Mol. Cell. Biol., June 1, 2005; 25(11): 4529 - 4540. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |